Pennsylvania bills · 2025-2026 Regular Session
Pennsylvania SB 866
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Michele Brooks (Republican)
Cosponsors (3)
- Doug Mastriano (Republican)
- Christine Tartaglione (Democratic)
- Lisa Boscola (Democratic)
Summary
No official summary is available for this bill.
Latest action(Jun 10, 2026): Referred to Judiciary
Text versions
Roll-call votes
State vote data last updated Oct 16, 2026, 12:24 AM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Jun 9, 2026 Senate | FINAL PASSAGE | pass | Set your home in Pennsylvania to see |
| Jun 8, 2026 Senate | Committee vote (Appropriations): Re-Reported as Committed | pass | Set your home in Pennsylvania to see |
| Jun 2, 2026 Senate | Committee vote (Agriculture & Rural Affairs): Reported as Committed | pass | Set your home in Pennsylvania to see |
Actions
- Jun 10, 2026 · House
Referred to Judiciary - Jun 9, 2026 · Senate
Third consideration and final passage - Jun 8, 2026 · Senate
Re-reported as committed - Jun 3, 2026 · Senate
Re-referred to Appropriations - Jun 3, 2026 · Senate
Second consideration - Jun 2, 2026 · Senate
First consideration - Jun 2, 2026 · Senate
Reported as committed - Jul 24, 2025 · Senate
Referred to Agriculture & Rural Affairs